Position in CSTL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,458,766
+$3,669,561 QoQ
Shares Held
222,353
+383.4% QoQ
Ownership
0.733%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in CSTL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PANAGORA ASSET MANAGEMENT INC holds $167,420,199 across 15 Diagnostics & Research names. CSTL ranks #6 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ILMN |
Illumina, Inc.
|
301,815 | $37,201,716 | |
| 2 | NTRA |
Natera, Inc.
|
172,730 | $34,544,272 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
60,028 | $28,824,845 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
147,215 | $25,106,046 | |
| 5 | A |
Agilent Technologies, Inc.
|
204,754 | $23,337,860 | |
| 6 | CSTL |
Castle Biosciences Inc
This page
|
222,353 | $5,458,766 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
6,513 | $3,201,334 | |
| 8 | VCYT |
Veracyte, Inc.
|
93,941 | $3,025,839 |
All Filings in CSTL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,458,766 | 222,353 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,789,205 | 45,995 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $487,232 | 21,398 | Shares | Sole | 2025-11-13 | |
| 2021-06-30 | $2,053 | 28 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $1,082,390 | 16,119 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $810,388 | 15,751 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $593,881 | 15,757 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $398,410 | 13,365 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||